33089-61-1 Usage
Uses
1. Agricultural Uses:
Amitraz is used as an insecticide and acaricide for controlling pests such as red spider mites, leaf miners, scale insects, and aphids on various crops.
It is also used as a veterinary medicine for treating demodectic mange in dogs.
2. Insecticide and Acaricide:
Amitraz is used as an insecticide and acaricide to control pests on fruit, cotton, and vegetables, as well as for controlling ticks, mange mites, lice, and other pests on cattle, dogs, sheep, and hogs.
3. Coccidiostat and Antiplatelet:
Although not explicitly mentioned in the provided materials, Amitraz is also used as a coccidiostat in the poultry industry to control coccidiosis, a disease caused by protozoan parasites. It may also have potential applications as an antiplatelet agent due to its effects on certain enzymes.
4. Control of Specific Pests:
Used in the control of pear psylla on pears, whitefly and mites on pears and cotton, bollworms, white fly, leaf worms, and tobacco budworms on cotton.
Indication and contradiction
Amitraz is indicated for animal use against mites, lice and ticks for cattle, swine and sheep. For dogs, it is used against ticks and mite[11]. It was reported as the drug of choice in the treatment of localized and generalized demodicosis in dogs[11]. Along with macrocyclic lactones such as milbemycin oxime, ivermectin, moxidectin, and doramectin, amitraz is still recommended for the treatment of generalized canine demodicosis, although it is not very efficient in adult-onset demodicosis cases[12]. Chesney (1989) also reported the use of amitraz in the treatment of demodicosis in cats[13]. Gunaratnam et al. (1983)[14] evaluated amitraz toxicity in cats, and concluded that low concentrations, around 0,0125% are capable of generating moderate toxic effects, especially anorexia. The toxic effects are even more evident in cats, due to their licking habit, resulting in a higher intake of the product. However, it is possible to use amitraz topically in healthy cats, respecting the appropriate contraindications common to the other species, which is to avoid the use in diabetic, hypothermic, and cardiac patients.
Amitraz is contraindicated in horses due to the risk of hypomotility and intestinal atony, leading to severe intestinal impaction[13, 14]. It has been also observed, besides the intestinal symptoms, the occurrence of neurologic signs as drowsiness, decreased cranial nerve reflexes and ataxia in horses submitted to the experimental use of amitraz. This substance is contraindicated for patients with extended skin injuries, which could lead to an over absorption, favoring intoxication.
Pharmacokinetics and pharmacodynamic
Amitraz is quickly hydrolyzed in an acid environment when it is orally administrated, due to its instability in this environment. The hydrolysis in a low pH generates the compound 2,4-dimethylphenyl formamide, which is stable in an acid environment. This substance can still be hydrolyzed, generating 2,4-dimethylaniline[15]. Absorption is effective through the skin, which may be major or minor depending on its integrity, the occurrence of injuries, and inflammation. After reaching the blood stream, the drug reaches the highest plasmatic level in up to two hours. The biotransformation occurs in the liver, generating the active metabolite BTS 27271, the most important pharmacologically, because it acts directly in the regulation of the insulin and glucagon secretion by binding to the α2A and α2D-adrenergic receptors, inhibiting insulin and stimulating glucagon secretion, resulting in hyperglycemia. Metabolites are excreted in bile and urine.
In insects, formamidines such as chlordimeform and amitraz operate its toxic effects by interacting with octopaminergic receptors in the central nervous system[16]. The mechanisms by which the deleterious effects of amitraz in mammals are determined are based on its agonistic action on α2-adrenergic receptors and inhibitory action over the monoamine oxidase (MAO), but there are reports of various action pathways, such as: H1 histamine receptor inhibition, prostaglandin synthase inhibition, adenylyl cyclase inhibition, voltage-gated calcium channels activation, reactive oxygen species generation, cell death induction and endocrine disruptions. Amitraz is also related to the emergence of neurotoxic effects and modifications in the reproductive sphere in rats[17].
Reference
USEPA (United States Environmental Protection Agency) (1996)
McDougall K and Lewis I (1984). Aust Vet J 61,137–140.
Eamens G, Spence S and Turner M (2001) Aust Vet J 79,703–706.
Shaw S and Foster A (2000) Aust Vet J 78,243–244.
Weichel L and Nauen R (2003) Pest Manage Sci 59,991–998.
Schaub L, Sardy S and Capkun G (2002) Pest Manage Sci 58,959–963.
JMPR. Pesticide Residues in Food?1998, Evaluations Part II: Toxicological WHO/PCS/99.18, 1998
Knowles, C. O., and Benezet, H. J. (1981) J. Environ. Sci. Health, Part B 16, 547?555.
Schuntner, C. A., and Thompson, P. G. (1978) Aust. J. Biol. Sci. 31, 141?148.
Pass, M. A., and Mogg, T. D. (1991) Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 99, 169?172.
Folz, S.D et al. Veterinary Parasitology, 16(3-4): 335–341, 1984.
Mueller, R.S. Veterinary Dermatology, 15: 75-89, 2004
Chesney, C.J. Journal of Small Animal Practice, 30(12): 689-695, 1989
Gunaratnam, P.; Wilkinson, G.T.; Seawright, A.A. Australian Veterinary Journal, 60(9): 278–279, 1983.
Pierpoint, A.C.; Hapeman, C.J.; Torrents, A. Journal of Agricultural and Food Chemistry's. 45(5): 1937-1939,1997.
Chen, A.C.; He, H.; Davey, R.B. Veterinary Parasitology, 148: 379-383, 2007.
Del Pino, J.; et al Chemical Research in Toxicology, 28(6): 1073-1094, 2015.
Costa, L. G., Wu, D. S., Olibet, G., and Murphy, S. D. (1989) Neurotoxicol. Teratol. 11, 405?411.
Douglas, W. W. (1980) Histamine and 5-Hydroxytryptamine (Serotonin) and Their Antagonist, in The Pharmacological Basis of Therapeutics., pp 609?646, Macmillan, New York.
Levitt, P., et al. (1997) Trends Neurosci. 20, 269?274.
Fajardo, A. M., et al (2014) Cancers 6, 436?458.
Shin, D. H., and Hsu, W. H. (1994) Toxicol. Appl. Pharmacol. 128, 45?49.
Radakovic, M., et al J. Biosci. (New Delhi, India) 38, 53?62.
Gregorc, A., and Bowen, I. D. (2000) Cell Biol. Int. 24, 319?324.
Originator
Aludex,Hoechst Roussel
Vet Ltd.
Manufacturing Process
A mixture of 55.1 g 2,4-dimethylaniline hydrochloride, 83.7 g ptoluenesulphonyl
chloride and 150 ml N-methylformamide was stirred with
occasional cooling to maintain the temperature at 20°-35°C. When the
exothermic reaction had subsided, the mixture was stirred at room
temperature for 4 h, poured into a mixture of ice and water, and basified with
10 N sodium hydroxide solution, keeping the temperature of the mixture below 10°C. The precipitated solid was filtered, washed with water until free
from alkali, dried at room temperature, to give N-2,4-dimethylphenyl-N'-
methylformamidine, melting point 75°-76°C (recrystallized from cyclohexane).
A solution of 19.4 g N-2,4-dimethylphenyl-N'-methylformamidine and 0.3 g ptoluenesulphonic
acid in 195 ml dry xylene was refluxed under anhydrous
conditions for 48 h, causing the evolution of methylamine. The xylene was
distilled off under reduced pressure to give 1,5-di-(2,4-dimethylphenyl)-3-
methyl-1,3,5-triaza-penta-1,4-diene, melting point 88°-89°C (crystallized
twice from isopropyl).
Therapeutic Function
Acaricide, Scabicide, Tickicide, Appetite stimulant
Air & Water Reactions
Insoluble in water.
Reactivity Profile
Unstable in acid.
Trade name
AAZDIENO?; ACARAC?; ACADREX?;
ARMY?; AZODIENO?; BAAM?; BOOTS BTS
27419?; BTS 27,419?; BUMETRAN?; COYOTE?;
DANICUT?; ECTODEX?; EDRIZAN?; EDRIZAR?;
GARIAL?; ISTAMBUL?; MITABAN?; MITAC?;
OVASYN?; OVIDREX?; PARSEC?; ROTRAZ?;
SENDER?; TAC-PLUS?; TACTIK?; TRIATIX?;
TRIATOX?; TUDY?; VAPCOZIN TAKTIC?; UPJOHN
U-36059?
Pharmacology
The mechanism of action of amitraz has not been
completely elucidated, and, presently, a dual mode of
action appearsmost likely. Firstly, the enzymemonoamine
oxidase, which metabolizes neurotransmitter amines in
mites and ticks, is inhibited. Secondly, octopamine
receptors in the central nervous system of ectoparasites
are activated by amitraz, thereby modifying tonic muscle
contractions. The effect of amitraz is to induce increased
neuronal activity, abnormal behavior, detachment, and
death of mites and ticks.
Potential Exposure
Those engaged in the manufacture, formulation
and application of this insecticide and acaricide. A
rebuttable presumption against registration for amitraz was
issued on April 6, 1977 by United States Environmental
Protection Agency on the basis of oncogenicity.
Incompatibilities: Keep away from strong oxidizers and
strong acids. Acids may render this material unstable.
Veterinary Drugs and Treatments
In dogs, amitraz solution is used topically primarily in the treatment of generalized demodicosis. A topical spot-on solution (ProMeris?
for Dogs) and a collar (Preventic?) are available for treatment and prevention of flea and tick infestation. It is also used as a general insecticidal/
miticidal agent in several other species (see label information). The pharmacologic action of amitraz is not well understood, but
it is a monoamine oxidase (MAO) inhibitor (in mites) and may have effects on the CNS of susceptible organisms. It apparently also possesses
alpha-2 adrenergic activity and inhibits prostaglandin synthesis. Amitraz can cause a significant increase in plasma glucose levels,
presumably by inhibiting insulin release via its alpha2-adrenergic activity. Yohimbine (alpha2 blocker) or atipamezole can antagonize this
effect.
Metabolic pathway
14C-Amitraz is applied on lemons grown under
glasshouse conditions at final harvest and the applied
radioactivity is quantitatively recovered, predominantly
in the peel (86%). The total residue at harvest
contains amitraz, N-methyl-N'-(2,4-xylyl)formamidine,
and formyl-2',4'-xylydine and conjugates of 4-amino-
m-toluic acid and the conjugated metabolites which
are convertible to 2,4-xylidine. Amitraz is readily
hydrolyzed at low pH values, forming acid-stable
formyl-2,4-xylydine which can be further hydrolyzed to
2,4-xylidine.
Metabolism
Amitraz is poorly absorbed when applied topically to
animals. By contrast, orally administered amitraz is
rapidly and extensively absorbed. The metabolism and
excretion of amitraz are also rapid. It is hydrolyzed to
N-(2,4-dimethylphenyl)-N -methyl formamidine and 2,4-
dimethyl formamidine and the final product, 4-amino-3-
methylbenzoic acid, is converted to non-toxic conjugates.
The latter are excreted in the urine and, to a lesser extent,
in bile.
Degradation
Amitraz is readily hydrolysed at acidic pH but is relatively stable under
alkaline conditions. Its DT50 values at 25 °C at pH 5,7 and 9 are given as
2.1,22.1 and 25.5 hours, respectively (PM). A recent study (Pierpoint et aE.,
1997) as part of the development of a vat management and waste disposal
programme for animal dips describes the kinetics and mechanism of
hydrolysis of amitraz in detail. Pseudo-first-order rate constants are given
for six pH values between 3.24 and 9.12. The DT50 values at pH values
3.24, 5.09 and 9.12 were respectively 0.4, 8.7 and 112 hours. The reaction
was mainly acid-catalysed with a small unassisted component. There was
no base catalysis. One of the primary products (Scheme 1) was N-2,4
dimethylphenyl-N-methylformamidine( 2); however, at low pH this was
not detected because it was rapidly hydrolysed to 2,4-dimethylphenylformamide
(3). Some direct hydrolysis of amitraz to product 3 was
also seen. The latter underwent slow base-catalysed hydrolysis to 2,4
dimethylaniline (4). This was a much slower reaction with a DT50 (pH
9.12) of about 300 days.
Toxicity evaluation
Amitraz displays serotonin (5-hydroxytryptamine) blocking
activity and a2-adrenoceptor agonist activity in animals.
The clinical signs associated with intoxication in
dogs include sedation, bradycardia, hypotension, hyperglycaemia,
hypothermia, and mydriasis. The specific antidote
for animal toxicity is the a2-adrenoceptor antagonist,
yohimbine. The toxicity profile of amitraz in the horse
includes transient sedation and intestinal stasis that can
progress to impaction colic (79). For this reason, amitraz
is not approved for use in this species in any country.
Incompatibilities
Those engaged in the manufacture, formulation
and application of this insecticide and acaricide. A
rebuttable presumption against registration for amitraz was
issued on April 6, 1977 by United States Environmental
Protection Agency on the basis of oncogenicity.
Incompatibilities: Keep away from strong oxidizers and
strong acids. Acids may render this material unstable.
Check Digit Verification of cas no
The CAS Registry Mumber 33089-61-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,0,8 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 33089-61:
(7*3)+(6*3)+(5*0)+(4*8)+(3*9)+(2*6)+(1*1)=111
111 % 10 = 1
So 33089-61-1 is a valid CAS Registry Number.
InChI:InChI=1/C19H23N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3/b20-12+,21-13+
33089-61-1Relevant articles and documents
Preparation method of amitraz
-
Paragraph 0079-0104, (2018/03/24)
The invention provides a preparation method of amitraz, which comprises the steps of (1) mixing 2,4-methyl toluidine, N-methyl formamide, triethyl orthoformate and a catalyst to obtain a mixture, (2)heating the mixture to allow the mixture to react, and volatilizing alcohol and ethyl formate to obtain final reaction liquid, and (3) cooling the final reaction liquid to a room temperature, and adding an organic solvent for crystallization to obtain the amitraz. The method has the advantages of greenness, environmental protection, high efficiency, economy, short reaction period, high product purity and the like.
Macrocyclic plant acaricides
-
, (2008/06/13)
Compounds of the formula I STR1 in which either R is methyl and there is a double bond in the 9,10-position, or in which R is hydrogen and there is a single bond in the 9,10-position, are highly active against Acarina which damage plants.
